Overall, the results obtained in the present study demonstrate that gram-positive gut microbiota, the associated metabolites, and their crosstalk with the host drive dyslipidemia and insulin resistance in iNOS−/− mice. This evidence concerns the gene NOS2 and metabolic syndrome.